ENSC ENSYSCE BIOSCIENCES INC revenue, earnings and financials
For the quarter ended June 30, 2026, ENSYSCE BIOSCIENCES INC reported revenue of $1.16M (down 15.1% from a year earlier), net income of −$2.57M and diluted EPS of −$0.20; over the last four quarters revenue was $4.50M and net income −$12.6M; for the fiscal year ended December 2025 revenue was $5.07M, down 2.8% on the year before.
ENSC annual revenue and earnings
- Fiscal year ended Dec 2025: revenue $5.07M, gross profit n/a, operating income −$10.2M, net income −$10.2M (margin -200.8%), EPS −$3.98
- Fiscal year ended Dec 2024: revenue $5.21M, gross profit n/a, operating income −$6.73M, net income −$7.99M (margin -153.3%), EPS −$11.45
- Fiscal year ended Dec 2023: revenue $2.23M, gross profit n/a, operating income −$10.7M, net income −$10.6M (margin -476.4%), EPS −$70.40
- Fiscal year ended Dec 2022: revenue $2.52M, gross profit n/a, operating income −$24.2M, net income −$24.2M (margin -959.3%), EPS −$139.42
- Fiscal year ended Dec 2021: revenue $3.53M, gross profit n/a, operating income −$19.9M, net income −$29.1M (margin -825.4%), EPS −$1.48
ENSC quarterly revenue and earnings
- Quarter ended Jun 30, 2026: revenue $1.16M (down 15.1% year over year), net income −$2.57M, EPS −$0.20
- Quarter ended Mar 31, 2026: revenue $961K (down 27.2% year over year), net income −$3.56M, EPS −$0.52
- Quarter ended Dec 31, 2025 (from the annual report): revenue $1.88M (up 44.4% year over year), net income −$2.77M, EPS −$0.51
- Quarter ended Sep 30, 2025: revenue $493K (down 85.6% year over year), net income −$3.73M, EPS −$1.29
- Quarter ended Jun 30, 2025: revenue $1.37M (up 654.4% year over year), net income −$1.73M, EPS −$0.79
- Quarter ended Mar 31, 2025: revenue $1.32M (up 331.7% year over year), net income −$1.95M, EPS −$1.39
- Quarter ended Dec 31, 2024 (from the annual report): revenue $1.30M (up 153.1% year over year), net income −$3.56M, EPS −$0.89
- Quarter ended Sep 30, 2024: revenue $3.42M (up 685.3% year over year), net income $662K, EPS $1.00
- Quarter ended Jun 30, 2024: revenue $182K (down 62.9% year over year), net income −$1.97M, EPS −$3.35
- Quarter ended Mar 31, 2024: revenue $306K (down 61.3% year over year), net income −$3.12M, EPS −$8.21
- Quarter ended Dec 31, 2023 (from the annual report): revenue $515K (down 64.1% year over year), net income −$3.50M, EPS −$66.47
- Quarter ended Sep 30, 2023: revenue $435K (up 55.9% year over year), net income −$2.69M, EPS −$0.87
- Quarter ended Jun 30, 2023: revenue $490K (up 136.4% year over year), net income −$2.24M, EPS −$0.98
- Quarter ended Mar 31, 2023: revenue $790K (up 30.9% year over year), net income −$2.19M, EPS −$2.08
- Quarter ended Dec 31, 2022 (from the annual report): revenue $1.43M (down 12.3% year over year), net income −$5.48M, EPS n/a
- Quarter ended Sep 30, 2022: revenue $279K (down 76.7% year over year), net income −$9.86M, EPS −$61.58
- Quarter ended Jun 30, 2022: revenue $207K (down 53.3% year over year), net income −$7.92M, EPS −$56.49
- Quarter ended Mar 31, 2022: revenue $603K (up 140.7% year over year), net income −$951K, EPS n/a
- Quarter ended Dec 31, 2021 (from the annual report): revenue $1.64M, net income −$9.34M, EPS −$0.44
- Quarter ended Sep 30, 2021: revenue $1.20M, net income −$17.2M, EPS −$0.71
ENSC cash flow, buybacks and dividends
- Fiscal year ended Dec 2025: operating cash flow −$7.81M, share buybacks n/a
- Fiscal year ended Dec 2024: operating cash flow −$7.50M, share buybacks n/a
- Fiscal year ended Dec 2023: operating cash flow −$10.8M, share buybacks n/a
- Fiscal year ended Dec 2022: operating cash flow −$17.9M, share buybacks n/a
- Fiscal year ended Dec 2021: operating cash flow −$8.24M, share buybacks n/a
ENSC balance sheet
- Jun 30, 2026: cash $677K, total assets $2.96M, total liabilities $4.07M, shareholders' equity −$782K
- Mar 31, 2026: cash $745K, total assets $2.17M, total liabilities $2.84M, shareholders' equity −$340K
- Dec 31, 2025: cash $4.31M, total assets $7.45M, total liabilities $4.57M, shareholders' equity $3.21M
- Sep 30, 2025: cash $1.67M, total assets $3.18M, total liabilities $2.30M, shareholders' equity $1.20M
- Jun 30, 2025: cash $2.21M, total assets $5.57M, total liabilities $2.51M, shareholders' equity $3.39M
- Mar 31, 2025: cash $3.05M, total assets $4.61M, total liabilities $1.89M, shareholders' equity $3.05M
- Dec 31, 2024: cash $3.50M, total assets $5.60M, total liabilities $2.22M, shareholders' equity $3.71M
- Sep 30, 2024: cash $4.15M, total assets $9.38M, total liabilities $2.80M, shareholders' equity $6.91M
What is ENSC's revenue?
ENSYSCE BIOSCIENCES INC reported $4.50M of revenue over its last four quarters, through June 30, 2026.
Is ENSC profitable?
No. ENSYSCE BIOSCIENCES INC lost $12.6M over the last four quarters.
What is ENSC's EPS?
Diluted earnings per share over the last four quarters were −$2.52; −$0.20 in the latest quarter.